T 115 (Lamivudine and zidovudine 150 mg / 300 mg)

Pill imprint T 115 has been identified as Lamivudine and zidovudine 150 mg / 300 mg.

Lamivudine/zidovudine is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamivudine and zidovudine

Imprint:

T 115

Strength:

150 mg / 300 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Exelan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.